Drug intelligence / Profile preview

xiaoer fuxiekang

Development stage: Unknown
Lead developer: Sichuan Beidaer New Technology Development
Administration: Oral

Overview

Xiaoer Fuxiekang is a Traditional Chinese Medicine (TCM) granule formulation developed and manufactured by Sichuan Beidaer New Technology Development. It is primarily indicated for the treatment of pediatric diarrhea, specifically those classified under the Damp-Heat Internal Accumulation syndrome. The formulation is composed of several herbal ingredients, including *Puerariae Lobatae Radix*, *Coptidis Rhizoma*, and *Poria*, which work synergistically to clear heat, resolve dampness, and stabilize the gastrointestinal tract. Clinical studies, such as the Phase 3 trial CTR20130877, have further evaluated its efficacy and safety in treating pediatric diarrhea and associated conditions like viral and rotavirus enteritis. It is an NMPA-approved pharmaceutical product in China.

Brand names: Xiaoer Fuxiekang
Other names: Xiaoer Fuxiekang Granules小儿腹泻康颗粒

Beyond the preview

Go deeper on xiaoer fuxiekang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiaoer fuxiekang.

Explore the full profile